Casdin Capital, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$4,231,800
-61.7%
90,000
-76.6%
0.37%
-68.5%
Q1 2020$11,057,000
-33.4%
385,000
+67.4%
1.17%
-23.1%
Q4 2019$16,604,000
-100.0%
230,000
-42.5%
1.53%
-73.7%
Q3 2019$56,116,000,000
-23.4%
400,0000.0%5.81%
-15.3%
Q2 2019$73,236,000,000
+115014.7%
400,0000.0%6.86%
-1.9%
Q1 2019$63,620,000
+112.9%
400,000
+28.2%
6.99%
+36.7%
Q4 2018$29,886,000
-32.2%
312,0000.0%5.11%
-4.5%
Q3 2018$44,070,000
+12.6%
312,000
+24.8%
5.36%
-2.1%
Q2 2018$39,133,000
-2.8%
250,0000.0%5.47%
-22.7%
Q1 2018$40,268,000
-2.2%
250,0000.0%7.08%
-29.4%
Q4 2017$41,178,000
+175.4%
250,000
+4.2%
10.03%
+137.5%
Q3 2017$14,952,000
-26.4%
240,000
-5.9%
4.22%
-43.8%
Q2 2017$20,308,000
+12.1%
255,0000.0%7.51%
-29.7%
Q1 2017$18,123,000
+36.8%
255,000
-1.7%
10.69%
-2.3%
Q4 2016$13,250,000
+8.0%
259,500
-2.6%
10.94%
+10.1%
Q3 2016$12,272,000
+38.8%
266,500
-9.2%
9.94%
+12.9%
Q2 2016$8,843,000
+45.9%
293,500
+55.3%
8.80%
+26.6%
Q1 2016$6,059,000
-27.3%
189,000
+32.2%
6.95%
-5.6%
Q4 2015$8,338,000143,0117.37%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders